Open AccessEfficacy and toxicity of intravesical Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer
Author(s) -
Yuki Matsuoka,
Rikiya Taoka,
Kana Kohashiguchi,
Yoichiro Tohi,
Yoshimasa Miyauchi,
Takuma Kato,
Hiroyuki Tsunemori,
Nobufumi Ueda,
Mikio Sugimoto
Publication year - 2021
Publication title -
current urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.476
H-Index - 13
eISSN - 1661-7657
pISSN - 1661-7649
DOI - 10.1097/cu9.0000000000000011
Subject(s) - medicine , clinical endpoint , bladder cancer , adverse effect , toxicity , retrospective cohort study , urinary system , urology , cancer , surgery , clinical trial
This study aimed to compare the efficacy and toxicity of intravesical Bacillus Calmette-Guérin (BCG) therapy between elderly and younger patients with non-muscle-invasive bladder cancer (NMIBC).